ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 55 filers reported holding ADICET BIO INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.3%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $180,009 | -26.6% | 131,393 | +30.3% | 0.00% | – |
| Q2 2023 | $245,100 | -57.5% | 100,864 | +0.8% | 0.00% | – |
| Q1 2023 | $576,230 | -35.3% | 100,040 | +0.3% | 0.00% | – |
| Q4 2022 | $891,255 | -53.4% | 99,693 | -25.9% | 0.00% | – |
| Q3 2022 | $1,913,000 | +13.9% | 134,491 | +16.9% | 0.00% | – |
| Q2 2022 | $1,679,000 | -31.1% | 115,030 | -5.8% | 0.00% | – |
| Q1 2022 | $2,438,000 | +29.8% | 122,099 | +13.8% | 0.00% | – |
| Q4 2021 | $1,878,000 | +154.8% | 107,300 | +13.9% | 0.00% | – |
| Q3 2021 | $737,000 | -17.7% | 94,196 | +8.3% | 0.00% | – |
| Q2 2021 | $895,000 | +59.8% | 86,988 | +103.2% | 0.00% | – |
| Q1 2021 | $560,000 | -7.0% | 42,803 | -0.1% | 0.00% | – |
| Q4 2020 | $602,000 | +55.2% | 42,846 | +31.2% | 0.00% | – |
| Q3 2020 | $388,000 | – | 32,650 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |